Search Results for “” – Page 9 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Observational Clinical outcomes Change patient management

236 Publications found

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.

b

Cardiovascular diabetology

October 19, 2021

p Diabetes

c Change patient management Clinical outcomes Observational Operational efficiencies
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.

b

BMC medicine

October 1, 2021

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.

b

British journal of cancer

October 1, 2021

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Next-Generation Sequencing-Directed Therapy in Patients with Metastatic Breast Cancer in Routine Clinical Practice.

b

Cancers

September 11, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results.

b

Inflammatory intestinal diseases

September 1, 2021

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational Operational efficiencies
Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and its influence on patient in-hospital outcome: a retrospective study.

b

Coronary artery disease

September 1, 2021

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.

b

JCO precision oncology

August 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction.

b

Crohn's & colitis 360

July 1, 2021

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Real-world data on treatment outcomes in -mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.

b

Future oncology (London, England)

July 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.

b

Clinical lung cancer

July 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational